Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine and Sperm Epigenetics (NEXT)
NCT05766345Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2023
- Primary completion
- Aug 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in Tuberculosis (TB), sponsored by Radboud University Medical Center. Started Oct 2023; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05766345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766345.